RAKSHARAB Profile



Product

RAKSHARAB
Company
Indian Immunologicals Ltd
Group
Allopathic
Subgroup
Vaccines
Main Combination
Vaccines & Biologicals
Storage
At 2C to 8C
Type
Injection  
Packing
Packing
Mrp
Tax
1 ml   
Rs 0   
+ inc.tax   
5 ml   
Rs 0   
+ inc.tax   
10 ml   
Rs 0   
+ inc.tax   
Indication
N/A
Composition
Raksharab vaccine contains tissue culture Rabies virus, CVS strain, produced on BHK21 cell line, and inactivated with aziridine compound. Aluminium hydroxide gel is used as adjuvant. Each ml of Raksharab contains antigen potency > 2.5 I.U. as per the standards specified by WHO.

Raksharab is recommended for immunisation of dogs and other domestic animals against rabies for prophylactic and post-exposure therapy (PET).

Dosage
Canine:
Vaccination Regimen :

Prophylactic use : At 3 months of age and above. In case primary vaccination is given below 3 months, a booster dose should be given at 3 months age.

Post - Exposure Therapy (Pet):

1st dose : On "0" day (the day of first vaccination)

2nd dose : 3rd day

3rd dose : 7th day

4th dose : 14th day

5th dose : 28th day

6th booster dose : 90th day

Immunity :

Immunity is conferred for a period of 3 years. However, annual vaccination is recommended in endemic areas.
1ml by subcutaneous or intramuscular route.
Sheep
Post - Exposure Therapy (Pet):

1st dose : On "0" day (the day of first vaccination)

2nd dose : 3rd day

3rd dose : 7th day

4th dose : 14th day

5th dose : 28th day

6th booster dose : 90th day

Immunity :

Immunity is conferred for a period of 3 years. However, annual vaccination is recommended in endemic areas.
Poultry
N/A
Large Animals
Cattle , camel and all other species - 1ml by subcutaneous or intramuscular route.

Vaccination Regimen :

Post - Exposure Therapy (Pet):

1st dose : On "0" day (the day of first vaccination)

2nd dose : 3rd day

3rd dose : 7th day

4th dose : 14th day

5th dose : 28th day

6th booster dose : 90th day

Immunity :

Immunity is conferred for a period of 3 years. However, annual vaccination is recommended in endemic areas.
Others
N/A
Administration
The vaccine vial should be thoroughly shaken before the contents are withdrawn. Only sterile syringes and needles should be used. The vaccine should be injected subcutaneously or intramuscularly through an area of clean, dry skin with all precautions taken against contamination.
Advantages
N/A
Precautions
Vaccinate only healthy animals. Malnutrition, helminth infestation, administration of immunosuppressive agents (like corticosteroids, radiation-therapy) will suppress immune response to the vaccine.

1. Generally no adverse reactions are noticed.

2. Occasionally a transient, palpable nodule may occur at the site of injection.

3.In rare cases hypersensitivity may occur, immediate treatment with antihistaminics is advocated.

Go Back